Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | NB003 |
Synonyms | |
Therapy Description |
NB003 is a PDGFRA and KIT inhibitor, which potentially inhibits tumor growth (Ann Oncol (2023) 34 (suppl_2): S1031). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
NB003 | NB-003|NB 003 | KIT Inhibitor 57 PDGFR-alpha Inhibitor 9 | NB003 is a PDGFRA and KIT inhibitor, which potentially inhibits tumor growth (Ann Oncol (2023) 34 (suppl_2): S1031). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04936178 | Phase I | NB003 | A Study of NB003 in Patients With Advanced Malignancies | Recruiting | USA | GBR | FRA | ESP | 2 |